FierceBiotech

“We need to pick a lane here as…

news2025-10-21T11:57:00+00:00October 21st, 2025|FierceBiotech|

GSK and Spero Therapeutics have…

news2025-10-21T10:36:00+00:00October 21st, 2025|FierceBiotech|

Neuphoria Therapeutics’ lead…

news2025-10-21T10:29:00+00:00October 21st, 2025|FierceBiotech|

Galapagos is planning to wind down…

news2025-10-21T09:10:00+00:00October 21st, 2025|FierceBiotech|

After rejecting Replimune’s…

news2025-10-20T17:18:00+00:00October 20th, 2025|FierceBiotech|

The U.S. private equity market is…

news2025-10-20T16:30:00+00:00October 20th, 2025|FierceBiotech|

As scientific disinformation…

news2025-10-20T13:05:00+00:00October 20th, 2025|FierceBiotech|

BioNTech is not planning further…

news2025-10-20T11:47:00+00:00October 20th, 2025|FierceBiotech|

Daiichi Sankyo and Merck & Co….

news2025-10-20T10:26:00+00:00October 20th, 2025|FierceBiotech|

Roche is forging ahead with plans…

news2025-10-20T09:03:00+00:00October 20th, 2025|FierceBiotech|

Previous757677Next